April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Manipulating Primer Position And Mass Dramatically Improves Quality Of Rb1 Exon Sequencing
Author Affiliations & Notes
  • Mallory K. Mest
    Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania
  • David W. Collins
    Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania
  • Joan M. O'Brien
    Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania
  • Footnotes
    Commercial Relationships  Mallory K. Mest, None; David W. Collins, None; Joan M. O'Brien, None
  • Footnotes
    Support  NEI's National Ophthalmic Disease Genotyping Network, NIH Grant EY13812, and The Wayne and Gladys Valley Foundation
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2488. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mallory K. Mest, David W. Collins, Joan M. O'Brien; Manipulating Primer Position And Mass Dramatically Improves Quality Of Rb1 Exon Sequencing. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2488.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Sanger sequencing is a common method used to test patients for mutations within the retinoblastoma gene (RB1). Obtaining high quality data from Sanger sequencing of RB1 is technically challenging due to homopolymer tracts bordering many exons and other sequence-related issues. We found these problems could be greatly improved by manipulating the size and position of sequencing primers.

Methods: : Position specific error probability estimates of individual base calls (QV) and length of read (LOR) were used to estimate DNA sequence quality for each primer/template combination. The performance of 64 different primers in 825 robotically assembled sequencing reactions was systematically quantified in the context of a highly automated diagnostic assay.

Results: : Sequence data quality from different sequencing primers under carefully controlled reaction conditions with the same DNA template varied widely and differences were reproducible and often highly significant. The mean probability of error was reduced by more than 99% for several regions of interest in RB1 by supplementing the PCR primer with a custom internal primer for sequencing and we are able to obtain bidirectional data from all RB1 exons, regardless of sequence context.

Conclusions: : We conclude that sequencing primer choice can be a critical determinant of success and quality for resequencing projects involving difficult templates and can provide more reliable results to patients and families with heritable retinoblastoma.

Keywords: retinoblastoma • genetics • mutations 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.